rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Melina Cioffi

SVP, Regulatory Affairs

Company insider

Files Form 4 as: SVP, Regulatory Affairs, Aquestive Therapeutics.

In numbers

Trades disclosed
10
Buys
0
Sells
1
Bought
$0
Sold
$211K
Companies
1
Companies where not an officer
0
First trade
15 May 2025
Last trade
15 May 2026
Last filed
18 May 2026

Companies traded

Where they are an officer
AQST Aquestive TherapeuticsOfficer · Pharmaceuticals · last 15 May 20260 buys · 1 sell

Activity over time

1 Mar – 1 Oct
10Mar 26May 26Jul 26Aug 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 May 2026filed 18 May 2026AQST Aquestive TherapeuticsPharmaceuticalsSEC FORM 4 Code F$6,9511,667 at $4.17filing
15 May 2026filed 18 May 2026AQST Aquestive TherapeuticsPharmaceuticalsSEC FORM 4 Code F$6,9511,667 at $4.17filing
10 Mar 2026filed 11 Mar 2026AQST Aquestive TherapeuticsPharmaceuticalsSEC FORM 4 Sold$106K25,311 at $4.17filing
10 Mar 2026filed 11 Mar 2026AQST Aquestive TherapeuticsPharmaceuticalsSEC FORM 4 Sold$106K25,311 at $4.17filing
9 Mar 2026filed 11 Mar 2026AQST Aquestive TherapeuticsPharmaceuticalsSEC FORM 4 Code A—100,000 at $0.00filing
9 Mar 2026filed 11 Mar 2026AQST Aquestive Therapeuticsoption or derivative · PharmaceuticalsSEC FORM 4 Code A$322K75,000 at $4.29filing
9 Mar 2026filed 11 Mar 2026AQST Aquestive Therapeuticsoption or derivative · PharmaceuticalsSEC FORM 4 Code A$322K75,000 at $4.29filing
9 Mar 2026filed 11 Mar 2026AQST Aquestive TherapeuticsPharmaceuticalsSEC FORM 4 Code A—100,000 at $0.00filing
2 Dec 2025filed 4 Dec 2025AQST Aquestive TherapeuticsPharmaceuticalsSEC FORM 4 Code F$12K2,083 at $5.93filing
15 May 2025filed 15 May 2025AQST Aquestive TherapeuticsPharmaceuticalsSEC FORM 4 Code A—20,000 at $0.00filing

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

John CochranDirector · Director at Aquestive Therapeutics, filing Form 4 there in the last year
Daniel BarberPresident and CEO · President and CEO at Aquestive Therapeutics, filing Form 4 there in the last year
Sherry KorczynskiChief Commercial Officer · Chief Commercial Officer at Aquestive Therapeutics, filing Form 4 there in the last year
Peter E. BoydChief People Officer · Chief People Officer at Aquestive Therapeutics, filing Form 4 there in the last year
Cassie JungChief Operating Officer · Chief Operating Officer at Aquestive Therapeutics, filing Form 4 there in the last year